DelveInsight's“ Obesity Pipeline Insigh t 2025 ” report provides comprehensive insights about 80+ companies and 100+ pipeline ...

Beverly Hills MD Metabolic Reset, a cutting-edge supplement designed to support natural weight management processes and ...

For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs), according to a study published online July 9 in ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Hormones can be helpful heroes, supporting the immune system and a healthy sleep-wake schedule. But they can also be culprits ...

Meal skipping, whether intentional or unintentional, triggers complex physiological, cognitive, and behavioral adaptations ...

Hengrui has reported topline data from the 301 study of their dual GLP-1 and GIP agonist HRS9531, administered as a ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...

The molecule, developed in collaboration with Massachusetts-based Kailera Therapeutics, is headed for a new drug application ...

Understanding the gut-brain axis is key to addressing eating disorders. This study highlights microbiota's influence and ...

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...